Results 121 to 130 of about 1,206,183 (180)

The effect of different types of drugs on balance and reaction ability of female abstainers. [PDF]

Sci Rep
Wang J, Zheng L, Wang S.
europepmc   +1 more source

Using knowledge in the field of psychology in criminal proceedings involving persons who use narcotic drugs and psychotropic substances

, 2020
Evgeniya Samolaeva, Tat'yana Borodkina
openalex   +1 more source

Use of Benzodiazepines in Medical Students: A Comparative Analysis Between Medical and Other University Degrees. [PDF]

Med Sci (Basel)
Fernández de Frutos P, García-Sánchez FJ, Mudarra-García N, Roque-Rojas F, Ihtisham-Kakakhel S, Luordo-Tedesco D.   +5 more
europepmc   +1 more source

How does psychoactive substance use affect health students? An important local cutout. [PDF]

Brain Behav Immun Health
Sampaio GR, Silva MBL, Soares DM, Braga-de-Souza S.   +3 more
europepmc   +1 more source

Forensic approaches to the classification of drug trafficking offenses, psychotropic substances, analogues or precursors

, 2019
Iryna Vashchenko
openalex   +1 more source

The analytical potential of the dry blood spot technique for pesticide biomonitoring - a review. [PDF]

Environ Monit Assess
Komajda K, Teresiński G.
europepmc   +1 more source

Changing trends in drug overdose mortality in Spain, 2001-2022. [PDF]

Addiction
Giné F, Donat M, Guerras JM, Barrio G, Belza MJ, Politi J, Regidor E.   +6 more
europepmc   +1 more source

Drugs and Drowning: The Toxicology of Adult Drownings in Baths and Hot Tubs in Australia, 2015-2024. [PDF]

Drug Alcohol Rev
Darke S, Farrell M, Duflou J, Copeland C, Roberts E.   +4 more
europepmc   +1 more source

Use of Psychoactive Substances Before Incarceration Among Prison Inmates With Drug Abuse or Dependence: Data From the OPPIDUM Program. [PDF]

Fundam Clin Pharmacol
Abbas Z, Lacroix C, Jouve E, Eiden C, Micallef J, Peyrière H, and the French Addictovigilance network.   +6 more
europepmc   +1 more source

Contribution of Addictovigilance data to assess adverse-events linked to psychoactive substances in children and adolescents. [PDF]

Br J Clin Pharmacol
Peyrière H, Batisse A, Sam-Laï NF, Daveluy A, Fournier-Choma C, Deheul S, Chevalier C, Lacroix C, Gibaja V, Aquizerate A, Pain S, Jouanjus E, Picot MC, Nogue E.   +13 more
europepmc   +1 more source